AAAAAA

   
Results: 1-10 |
Results: 10
PROGNOSTIC FACTORS IN PATIENTS WITH RECURRENT BREAST-CANCER FOLLOWINGMASTECTOMY
Authors: ICLI F CAY F DINCOL D KARAOGUZ H DEMIRKAZIK A AKBULUT H
Citation: F. Icli et al., PROGNOSTIC FACTORS IN PATIENTS WITH RECURRENT BREAST-CANCER FOLLOWINGMASTECTOMY, European journal of cancer, 34, 1998, pp. 500-500
SURGICAL RESECTION FOLLOWED BY ADJUVANT CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER WITH LIMITED DISEASE
Authors: ARICAN A DINCOL D AKBULUT H CAY F ICLI F KARAOGUZ H DEMIRKAZIK A
Citation: A. Arican et al., SURGICAL RESECTION FOLLOWED BY ADJUVANT CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER WITH LIMITED DISEASE, Annals of oncology, 9, 1998, pp. 509-509
COST-EFFECTIVENESS OF RADIONUCLIDE BONE SCANNING TO RULE OUT ASYMPTOMATIC BONE METASTASES IN CLINICALLY OPERABLE NONSMALL CELL LUNG-CANCER
Authors: ARICAN A DINCOL D SAMUR M DEMIRKAZLK A SENCAN O AKBULUT H KARAOGUZ H CAY F ICLI F
Citation: A. Arican et al., COST-EFFECTIVENESS OF RADIONUCLIDE BONE SCANNING TO RULE OUT ASYMPTOMATIC BONE METASTASES IN CLINICALLY OPERABLE NONSMALL CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 4-4
RESULTS OF THE CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE (CHOP)+ -BLEOMYCIN TREATMENT AND EVALUATION OF PROGNOSTIC FACTORS IN AGGRESSIVE LYMPHOMAS IN TURKEY/
Authors: DINCOL D AKBULUT H ICLI F SAMUR M KARAOGUZ H DEMIRKAZIK A CAY F
Citation: D. Dincol et al., RESULTS OF THE CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE (CHOP)+ -BLEOMYCIN TREATMENT AND EVALUATION OF PROGNOSTIC FACTORS IN AGGRESSIVE LYMPHOMAS IN TURKEY/, Oncology, 54(5), 1997, pp. 376-379
PHASE-II STUDY OF A MODIFIED COMBINATION OF ETOPOSIDE, DOXORUBICIN, AND CISPLATIN FOR PATIENTS WITH ADVANCED GASTRIC
Authors: ICLI F KARAOGUZ H AKBULUT H DINCOL D DEMIRKAZIK A CAY F
Citation: F. Icli et al., PHASE-II STUDY OF A MODIFIED COMBINATION OF ETOPOSIDE, DOXORUBICIN, AND CISPLATIN FOR PATIENTS WITH ADVANCED GASTRIC, Journal of surgical oncology, 64(4), 1997, pp. 318-323
2 DOSE LEVELS OF IFOSFAMIDE IN MALIGNANT MESOTHELIOMA
Authors: ICLI F KARAOGUZ H HASTURK S KURT B AKBULUT H DINCOL D DEMIRKAZIK A CAY F AKYAR S
Citation: F. Icli et al., 2 DOSE LEVELS OF IFOSFAMIDE IN MALIGNANT MESOTHELIOMA, Lung cancer, 15(2), 1996, pp. 207-213
RESULTS OF THE CYCLOPHOSPHAMIDE, ADRIAMYCINE, VINCRISTINE, PREDNISOLON (CHOP) + - BLEOMYCINE TREATMENT AND EVALUATION OF PROGNOSTIC FACTORSIN AGGRESSIVE LYMPHOMAS/
Authors: DINCOL D ICLI F AKBULUT H SAMUR M KARAOGUZ H DEMIRKAZIK A CAY F
Citation: D. Dincol et al., RESULTS OF THE CYCLOPHOSPHAMIDE, ADRIAMYCINE, VINCRISTINE, PREDNISOLON (CHOP) + - BLEOMYCINE TREATMENT AND EVALUATION OF PROGNOSTIC FACTORSIN AGGRESSIVE LYMPHOMAS/, European journal of cancer, 31A, 1995, pp. 784-784
THE VALUE OF FERRITIN IN THE DIFFERENTIAL-DIAGNOSIS OF MALIGNANT EFFUSIONS
Authors: DEMIRKAZIK A DINCOL D HASTURK S ARICAN A KARAOGUZ H ICLI F
Citation: A. Demirkazik et al., THE VALUE OF FERRITIN IN THE DIFFERENTIAL-DIAGNOSIS OF MALIGNANT EFFUSIONS, European journal of cancer, 31A, 1995, pp. 1269-1269
MESNA IFOSFAMIDE, MITOXANTRONE, ETOPOSIDE, BLEOMYCIN, VINCRISTINE, PREDNISONE (MINE-BOP) COMBINATION CHEMOTHERAPY IN THE TREATMENT OF REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA
Authors: DINCOL D ICLI F KARAOGUZ H CAY F ARICAN A DEMIRKAZIK A AKBULUT H
Citation: D. Dincol et al., MESNA IFOSFAMIDE, MITOXANTRONE, ETOPOSIDE, BLEOMYCIN, VINCRISTINE, PREDNISONE (MINE-BOP) COMBINATION CHEMOTHERAPY IN THE TREATMENT OF REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA, Acta oncologica, 34(7), 1995, pp. 937-940
SEVERE VASCULAR TOXICITY ASSOCIATED WITH CISPLATIN-BASED CHEMOTHERAPY
Authors: ICLI F KARAOGUZ H DINCOL D DEMIRKAZIK A GUNEL N KARAOGUZ R UNER A
Citation: F. Icli et al., SEVERE VASCULAR TOXICITY ASSOCIATED WITH CISPLATIN-BASED CHEMOTHERAPY, Cancer, 72(2), 1993, pp. 587-593
Risultati: 1-10 |